Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sulicon
    Member
    • Aug 2010
    • 41

    #1

    Weird results at the 51st nucleotide

    Hi all,

    We just got some bisulfite sequencing data from a set of patients. After running FastQC on a few samples, we observed an extremely low quality score at position #51, for two samples.

    Attached are the distribution of base quality scores, % of Ns, and the nucleotide composition at each position.

    My question is, what is the possible reason for this? Should we trim all the nucleotides after 50?

    Thanks in advance!
    Attached Files
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    There was probably a bubble that floated through the flowcell. That's a pretty common cause of random dips in quality. I wouldn't bother trimming that off, the dip in quality is only affecting a few bases. Any of the common aligners should still be able to accurately align the reads. Just choose one that allows you to set a minimum phred score during methylation extraction (i.e., one that will ignore methylation calls at those crappy bases).

    Comment

    • sulicon
      Member
      • Aug 2010
      • 41

      #3
      Thank you Devon for the explanation and suggestion.

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        Were these two samples on the same lane? Were there other samples besides these two in the lane that are not showing this problem?

        You should at least request your sequence provider to re-run the sample(s) at no cost (unless there were other samples in that lane that do not have this problem).

        Comment

        • sulicon
          Member
          • Aug 2010
          • 41

          #5
          We got the data from another group. There is no barcodes used, I assume each sample was sequenced on one entire lane. (right?)

          We have checked about 10 samples, two samples mentioned above have the problem at exactly the same position (#51). The two samples are in the control group.

          There are also other samples with problem at different position. Three of the case samples we checked have low quality base-calling at position #63 (see attached).

          It seems that the position of abnormal base-calling differs in a run-by-run manner.

          Originally posted by GenoMax View Post
          Were these two samples on the same lane? Were there other samples besides these two in the lane that are not showing this problem?

          You should at least request your sequence provider to re-run the sample(s) at no cost (unless there were other samples in that lane that do not have this problem).
          Attached Files

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            You are correct in that your samples must have been run in separate lanes, if there are no barcodes. It is possible that one or more lanes had a bubble flow though that affected the basecalls. You can look at the tile representation from FastQC to see if you can identify bad tiles across cycles.

            In general Q-scores take a nose dive when the nucleotide diversity no longer exists (or is significantly reduced). It appears that majority of the data in the example above consists of N's beyond cycle #63 and would likely need to be trimmed before analysis.

            Comment

            • sulicon
              Member
              • Aug 2010
              • 41

              #7
              Thank you GenoMax. I will trim the low quality bases as you suggested.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                by SEQadmin2



                Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                ...
                10-14-2026, 09:55 AM
              • SEQadmin2
                New Genomics Technologies Take Aim at Long-Standing Limits
                by SEQadmin2


                Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                ...
                09-28-2026, 10:25 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 10-22-2026, 11:13 AM
              0 responses
              40 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-22-2026, 10:48 AM
              0 responses
              29 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-15-2026, 10:52 AM
              0 responses
              42 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-14-2026, 05:39 AM
              0 responses
              45 views
              0 reactions
              Last Post SEQadmin2  
              Working...